Myeloma UK has today published their Position Paper on the Department of Health’s (DH) plans for a system of value-based pricing for new branded medicines from 1 January 2014. Central to the Myeloma UK Position Paper is a call for the National Institute for Health and Clinical Excellence (NIC.....
The Myeloma UK funded Research Programme at The Institute of Cancer Research (ICR) has made another important discovery about the genetics of myeloma. Researchers at the ICR have identified an inherited gene that increases the risk of developing myeloma by making the DNA more susceptible to damage. .....
Myeloma UK today published a report making recommendations on four key areas of value based pricing (VBP), the proposed pricing system for new branded medicines in 2014. In an attempt to drive forward the debate on medicine pricing, Myeloma UK created a forum of opinion leaders and experts fro.....
Myeloma UK welcomes the publication of the Department of Health (DH) response to the Value Based Pricing (VBP) Consultation and applauds its efforts to date on what is a very complex area. Whilst Myeloma UK values the opportunity to participate in this important debate, we do remain concerned about.....
Press release Hospital staff get baking in aid of Myeloma UK Over 60 County Hospital staff and patients are baking cakes on Tuesday 21st June in aid of Myeloma UK. The Bake-a-thon, part of Myeloma Awareness Week organised by Rachel Price-Jones, specialist cancer nurse, from The County Hospital,.....